Developing safer and more effective influenza vaccines
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE
This study is all about making better flu vaccines that work more effectively and have fewer side effects, so people can stay healthier during flu season.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10788137 on NIH RePORTER |
What this research studies
This research focuses on creating and improving influenza vaccines by utilizing advanced manufacturing techniques and evaluating their safety and toxicity. The team aims to innovate vaccine platforms that can provide better protection against the flu virus. Patients may benefit from vaccines that are not only more effective but also have fewer side effects. The research involves collaboration among experts in vaccine development to ensure high-quality outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are at high risk for influenza, such as the elderly, young children, and those with compromised immune systems.
Not a fit: Patients who are not at risk for influenza or those who have already received a flu vaccine may not receive significant benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a universal flu vaccine that offers broader protection with improved safety profiles.
How similar studies have performed: Other research has shown promise in developing innovative vaccine platforms, indicating that this approach has the potential for success.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Johnson, Matthew — Duke University
- Study coordinator: Johnson, Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.